0001140361-16-054004.txt : 20160218 0001140361-16-054004.hdr.sgml : 20160218 20160218184415 ACCESSION NUMBER: 0001140361-16-054004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160216 FILED AS OF DATE: 20160218 DATE AS OF CHANGE: 20160218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edge Therapeutics, Inc. CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1600 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1600 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Einhorn Andrew J. CENTRAL INDEX KEY: 0001560685 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 161439433 MAIL ADDRESS: STREET 1: C/O MYOS CORPORATION STREET 2: 45 HORSEHILL ROAD, SUITE 106 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 4 1 doc1.xml FORM 4 X0306 4 2016-02-16 0 0001472091 Edge Therapeutics, Inc. EDGE 0001560685 Einhorn Andrew J. 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 0 1 0 0 Chief Financial Officer Stock Option (Right to Purchase) 6.99 2016-02-16 4 A 0 50000 0 A 2026-02-16 Common Stock 50000 50000 D This option, representing a right to purchase a total of 50,000 shares of Common Stock, will become exercisable on February 16, 2017, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. /s/ Andrew J. Einhorn 2016-02-18